account_balance
Investment manager · 13F filer · SEC CIK 1674546
Bellevue Group AG
Reported value$4.75Bas of Jun 30, 2026
Positions148 17 new, 24 sold out
Top 10 weight43%AMGN alone is 6%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
AMGN
Amgen INC
6.5%Added
VRTX
Vertex Pharmaceuticals INC
6.0%Trimmed
ARGX
Argenx Se
5.9%Trimmed
GILD
Gilead Sciences INC
5.7%Added
RVMD
Revolution Medicines INC
4.1%Trimmed
ORKA
Oruka Therapeutics INC
3.3%Added
INSM
Insmed INC
3.1%Added
SRRK
Scholar Rock Hldg Corp
2.8%Trimmed
NUVL
Nuvalent INC
2.7%
VRDN
Viridian Therapeutics INC
2.6%
138 others
57.1%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed